Mount Sinai Neurosurgery’s Post

At nine years old, Carson Brooks was diagnosed with epilepsy. As he grew older, his seizures worsened despite taking an escalating number of pills to treat his epilepsy. To address these debilitating seizures, Aria Fallah, MD, MSc, Pediatric Neurosurgeon and Co-Medical Director of the Epilepsy Surgery Program, surgically implanted a device in Carson's brain to deliver responsive neurostimulation (RNS). RNS continuously monitors brain activity, detects oncoming seizures, and delivers a small electrical current to prevent seizures. RNS has offered hope to the third of patients – like Carson – with drug-resistant epilepsy and is a fairly new option for pediatric cases. RNS, along with a second surgery to remove some of the affected area in his brain, have led to a decrease in the intensity of Carson's seizures and an improvement in his quality of life. To learn more about RNS and Carson's story, please read the full article here: https://lnkd.in/g7ENnrja #Epilepsy #RNS #Neurosurgery

Hemispheric surgery for epilepsy is incredibly rewarding, often making young patients seizure-free and altering their lives profoundly. It took a global effort to create the Hemispherectomy Outcome Prediction Scale (HOPS), now freely and publicly available to aid prognostication. Truly heartwarming to see the incredible commitment to advancing epilepsy treatment worldwide 🌍. Special thanks to Dr. Alexander Weil, Dr. Evan Lewis, and Dr. George Ibrahim. Also Evan Dimentberg, M.D., M.Sc. & Joseph (Jia-Shu) Chen. Explore the HOPS calculator here: [HOPS Calculator](https://lnkd.in/gGs4N9nv). #hemispherectomy #neurosurgery #epilepsy

Hemispherectomy, or the surgical disconnection of one half of the brain from the other half and brainstem, is a type of epilepsy treatment for pediatric patients. While it is extreme, this procedure can be an integral step towards improving the lives of young patients with severe or drug-resistant epilepsy. Despite the largely positive outcomes hemispherectomy can offer, there remains a significant amount of variation in seizure outcomes for patients post-hemispherectomy. This variability, along with an array of potential side-effects, can lead to significant anxiety for families deciding whether their child should undergo hemispherectomy surgery. The Hemispherectomy Outcome Prediction Scale (HOPS), a tool spearheaded by Aria Fallah, MD, MSc, Pediatric Neurosurgeon and Dr. Alfonsina Q. Davies Endowed Chair in honor of Paul Crandall, M.D., for Epilepsy Research at UCLA, and a multi-institutional team, was developed to better predict seizure freedom for patients undergoing a hemispherectomy. To make this groundbreaking resource more widely accessible, Dr. Fallah and his team created an online calculator that would accurately predict the probability of seizure freedom post-hemispherectomy. For families faced with the uncertainty of a hemispherectomy, such a resource is invaluable. To view the HOPS calculator, visit the site here: https://lnkd.in/gGs4N9nv #hemispherectomy #neurosurgery #epilepsy

Hemimegalencephaly (HME) is a rare congenital neurological disorder that often results in drug-resistant epilepsy. Unfortunately, data to inform care can be limited. UCLA is one of a handful of centers in the U.S. with surgical expertise in HME. Pediatric Neurosurgeon Aria Fallah, MD, MSc and colleagues reported on outcomes and prognostic factors in 56 pediatric patients with HME-related drug-resistant epilepsy who underwent hemispheric surgery at UCLA from 1984 to 2021. Read the full article and findings here: https://lnkd.in/g2mNrvTF

🔬🧠 Delve into an interesting case report on "Strategy in the Surgical Treatment of Cystic Vestibular Schwannoma"!   Discover how a 67-year-old patient's symptoms led to the successful removal of a cystic tumor in the right pontocerebellar angle. Learn about the surgical techniques employed by the expert neurosurgery team at "St. Marina" University Hospital.   Read it here: https://lnkd.in/dgtzZDmg #Neurosurgery #CaseReport #MedicalInnovation #Healthcare 📝

Learn more about the #FRONTIERstudy: https://bit.ly/3UifcLi #recurrentGBM #TheraSphereGBM #Y90 Caution: Investigational Device. Limited by Federal (or US) law to investigational use only. Not available for sale. TheraSphere is not indicated for GBM, and is being studied for such in the FRONTIER clinical trial.

Go Behind The Bench of Lenox Hill Neurosurgery’s FRONTIER clinical trial, sponsored by Boston Scientific Peripheral Interventions. 🔬🧬 The aim of this study is to assess the safety and feasibility of the intra-arterial delivery of TheraSphere™ GBM Y-90 Glass Microspheres in patients with recurrent glioblastoma. Lenox Hill Hospital’s Chief of Neuroendovascular Surgery, Dr. Yafell Serulle, MD, PhD, Interventional Radiologist, Dr. Jonathan Weinstein, and Senior Clinical Research Project Manager, Sanskruti (Sana) Bokil, BS, MS, share how they combine their respective expertise to facilitate this trial and the importance of offering patients treatment at every stage of this disease.    Click the link for more information about the FRONTIER study or to contact our Clinical Research Team about enrolling in one of our clinical trials. 🧠   Caution: Investigational Device. Limited by Federal (or US) law to investigational use only. Not available for sale. TheraSphere is not indicated for GBM, and is being studied for such in the FRONTIER clinical trial. https://lnkd.in/eU_uvUB4   #lenoxhillneurosurgery #lenoxhillhospital #lenoxhill #northwellhealth #northwelllife #northwellcancerinstitute #bostonscientific #glioblastomaawarenessday #glioblastomaawareness #glioblastomaresearch #braintumorresearch #braincancerresearch #neurosurgery #neurosurgeon #madeforthis #raisinghealth #igreels #instagramreels #reels #fyp

Ophthopedia Update:Clinical Challenge: Looking beyond blurred margins: A 60-year-old man presented to an outside ophthalmology clinic with 1 month of progressive vision loss in the right eye (OD). Right optic disc edema was noted. Brain and orbit magnetic resonance imaging revealed right optic nerve and left occipital lobe enhancement. He was seen initially by neurology and neurosurgery and subsequently referred to neuro-ophthalmology for consideration of optic nerve biopsy. He was seen 3 months after his initial symptom onset where vision was light perception OD and a relative afferent pupillary defect with optic nerve edema. #Ophthalmology #Eye #Ophthotwitter

Child Neuro Synapses: Dispatches in Child Neurology Research," authored by CNS Connections editor Dr. Daniel Bonthius, is a valuable resource for staying updated on the latest advancements in child neurology. The latest feature includes "What’s the wait? Delays in epilepsy surgery." Dr. Bonthius provides summaries of the most impactful recent articles, ensuring practitioners stay informed on critical developments in the field. https://ow.ly/ZQMi50S7Rp7

According to a New England Journal of Medicine (NEJM Group) study, a dramatic, threefold reduction in repeat operations in patients surgically treated for chronic subdural hematoma was achieved when the artery supplying the brain covering was blocked! Headache, weakness and seizures may be symptoms of chronic subdural hematomas, which become more common as we age. To treat them, patients undergo brain surgery, but hematomas can recur, requiring additional surgery. The EMBOLISE clinical trial proves how it’s possible to sharply reduce the need for repeat surgeries. Of the 400 trial participants, 40 were enrolled through UBMD Neurosurgery (of UBMD Physicians' Group) and treated through the Gates Vascular Institute (of Kaleida Health). The national trial was led by Jason Davies, MD, PhD, associate professor of University at Buffalo Neurosurgery (UBNS) at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, and Jared Knopman, MD, associate professor of neurological surgery at Weill Cornell Medicine. The paper lists more than 40 co-authors from participating centers. » Learn more on why Davies says they are changing the treatment for this common disease: http://ms.spr.ly/6044W4yAG #UBuffalo #NEJM #SubduralHematoma #EMBOLISE #Neurosurgery #BuffaloNY #WesternNewYork #WNY